Back to top

Analyst Blog

Allscripts Healthcare Solutions (MDRX - Analyst Report) has now come up with a real-time and point of care solution Population Health Analytics that will help reduce high cost of chronic disease management and check readmissions.

MDRX will demonstrate the Analytics solution at The Allscripts Client Experience (ACE) at Chicago’s McCormick Place from Aug 21 to 23. It provides analytics for costly and high priority chronic maladies such as Diabetes, Heart Disease, Coronary Artery Disease and Asthma.

According to President and Chief Executive Officer of Allscripts, Paul M. Black, its Population Health Analytics indicates a move from individual patient care to population health care. The data generated by the Analytics help physicians identify target populations, measure performance and outcomes, and inform and guide prompt clinical intervention for chronic ailments and readmission risks.

Allscripts Healthcare Solutions is a leading clinical software and information solutions provider for physicians. Its products are used widely across the U.S. and Canada. Currently, the company serves approximately 180,000 physician practices, 1,500 hospitals, and 10,000 post acute care facilities.

Recently, Portland-Maine based Mercy Health System revealed that it has chosen Allscripts Healthcare Solutions’ Revenue Cycle Management (RCM) Services in order to improve their reimbursement processes at a lower cost and reduced implementation time. RCM Services provide a complete revenue management solution from front office to back office processing and patient collections.

A few days back, N.C.-based Appalachian Regional Healthcare System also announced that it has implemented Allscripts Healthcare Solutions’ Electronic Health Record (EHR) system known as Sunrise Clinical Manager (SCM). SCM will help Appalachian maintain integrated patient records with the same graphical interface across the health system.

Allscripts Healthcare Solutions posted a significant fall in adjusted earnings to $2.2 million or a penny per share in the second quarter of 2013 from $23.1 million or 13 cents in the comparable quarter of 2012. With this, earnings also missed the Zacks Consensus Estimate of 7 cents for the quarter.

Revenues in the quarter ebbed 6.8% to $344.8 million, again missing the Zacks Consensus Estimate of $358 million. The decrease can be attributable to lower revenues generated from all the operating segments.

While we avoid MDRX being a Zacks Rank #4 (Sell) stock, other scrips that are performing well in the medical products industry include Hanger, Inc. (HGR - Analyst Report) and Alere Inc. (ALR - Snapshot Report), both with a Zacks Rank #1 (Strong Buy), and in the medical information systems industry such as Medidata Solutions, Inc. (MDSO - Snapshot Report) with a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UNITED THER… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%